Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Income Growth
54.89%
Quarterly · Period ending:
LCTX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported54.89%period ending
Latest reported54.89%period ending
LCTX Quarterly Operating Income YoY % (-100.00% → 54.89%)
Year-over-year change
High-resolution chart · PNG
LCTX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 54.8888% | |
| -16.7256% | |
| -28.1409% | |
| 1.4063% | |
| -237.1399% | |
| 2.342% | |
| 19.6793% | |
| 42.7293% | |
| -16.7795% | |
| -0.2861% | |
| 4.1723% | |
| -27.69% | |
| -18.6585% | |
| -3.8462% | |
| 76.4891% | |
| 23.2647% | |
| 40.1977% | |
| 9.2766% | |
| -380.0748% | |
| -1.7546% | |
| -10.5904% | |
| 5.2165% | |
| 14.4063% | |
| 20.1496% | |
| 40.8373% | |
| 41.713% | |
| 32.0075% | |
| 18.683% | |
| -18.3399% | |
| -4.7099% | |
| -5.6886% | |
| -8.8721% | |
| 11.3782% | |
| -8.2135% | |
| 15.0182% | |
| 0.4396% | |
| 28.3621% | |
| 52.597% | |
| 48.1429% | |
| 44.1359% | |
| -6.7205% | |
| -75.9588% | |
| -50.6464% | |
| -40.9176% | |
| -3.3252% | |
| -21.2266% | |
| 50.8266% | |
| -18.9732% | |
| -60.9284% | |
| -32.9113% | |
| -315.0192% | |
| -71.5606% | |
| -33.509% | |
| -41.6592% | |
| -29.2679% | |
| -40.502% | |
| -222.0506% | |
| -46.9376% | |
| -45.4115% | |
| -72.2081% | |
| 315.1223% | |
| -203.5835% | |
| -316.5723% | |
| 16.2434% | |
| -109.0393% | |
| -45.527% | |
| 279.1118% | |
| -221.0955% | |
| -16.6763% | |
| -123.856% | |
| -276.0846% | |
| -487.0601% | |
| -223.1254% | |
| 21.0538% | |
| 24.323% | |
| 49.7024% | |
| 54.1785% | |
| -11.8335% | |
| 26.3822% | |
| 23.3366% | |
| -50.0981% | |
| 36.4501% | |
| 22.9177% | |
| 2.9467% | |
| 4.6367% | |
| -43.527% | |
| -60.2826% | |
| -16.4096% | |
| 9.1159% | |
| -8.55% | |
| 38.5962% | |
| -12.508% | |
| 14.0268% | |
| 12.9148% | |
| -40.6548% | |
| 65.9993% | |
| 49.0604% | |
| 44.1926% | |
| 58.3812% | |
| 27.3471% |